Eventide Asset Management’s Encompass Health EHC Stock Holding History

Eventide Asset Management’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.32M	Buy	72,385 +2,083	+3%	+$216K	0.1%	164
2026 Q1	$6.81M	Buy	70,302 +1,334	+2%	+$137K	0.11%	152
2025 Q4	$7.33M	Buy	+68,968	New	+$7.99M	0.11%	159
2024 Q1	–	Sell	-151,644	Closed	-$10.1M	–	165
2023 Q4	$10.1M	Sell	151,644 -18,464	-11%	-$1.2M	0.17%	120
2023 Q3	$11.4M	Sell	170,108 -19,871	-10%	-$1.37M	0.21%	116
2023 Q2	$12.9M	Hold	189,979	–	–	0.22%	113
2023 Q1	$10.3M	Sell	189,979 -4,516	-2%	-$263K	0.19%	115
2022 Q4	$11.6M	Hold	194,495	–	–	0.23%	101
2022 Q3	$8.8M	Buy	+194,495	New	+$9.73M	0.17%	107

Other funds holding EHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Eventide Asset Management's EHC Position: Q2 2026 in Review

Eventide Asset Management increased its Encompass Health (EHC) stake by 3% in Q2 2026, buying an estimated $216K and bringing the position to 72,385 shares worth $7.32M. The position accounts for 0.1% of the portfolio, ranked #164.

Eventide Asset Management first reported a position in EHC in Q3 2022 and has held it in 9 quarters since. The position peaked at $12.9M in Q2 2023. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

Eventide Asset Management held 72,385 shares of Encompass Health worth $7.32M as of Q2 2026.
Eventide Asset Management bought 2,083 Encompass Health shares in Q2 2026, an estimated $216K.
Encompass Health made up 0.1% of Eventide Asset Management's portfolio in Q2 2026, its #164 holding.
Eventide Asset Management first reported a position in Encompass Health in Q3 2022 and has held it in 9 quarters since.
Eventide Asset Management's Encompass Health position peaked at $12.9M in Q2 2023.
598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.